In vitro selection using modified or unnatural nucleotides

Current Protocols in Nucleic Acid Chemistry

Volumn , Issue SUPPL.56, 2014, Pages

  Stovall, Gwendolyn M ^a   Bedenbaugh, Robert S ^a   Singh, Shruti ^a   Meyer, Adam J ^a   Hatala, Paul J ^b   Ellington, Andrew D ^a   Hall, Bradley ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Altermune Technologies LLC   (United States)

Author keywords

Aptamer; Deoxyribozymes; In vitro selection; Modified nucleotides; Ribozymes; Unnatural nucleotides

Indexed keywords

APTAMER; NUCLEOTIDE DERIVATIVE; RIBOZYME; RNA DIRECTED DNA POLYMERASE; DNA; NUCLEOTIDE; RNA;

ARTICLE; BINDING AFFINITY; CATALYST; DISSOCIATION CONSTANT; DISULFIDE BOND; ENZYME DEGRADATION; HIGH THROUGHPUT SEQUENCING; HYDROLYSIS; IN VITRO SELECTION; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECONDARY STRUCTURE; REPRODUCIBILITY; REVERSE TRANSCRIPTION; SOLID PHASE SYNTHESIS;

DNA; NUCLEOTIDES; RNA;

EID: 84901593974     PISSN: 19349270     EISSN: 19349289     Source Type: Journal    
DOI: 10.1002/0471142700.nc0906s56     Document Type: Article

References (91)

1. Bartel, D.P. and Szostak, J.W. 1993. Isolation of new ribozymes from a large pool of random sequences. Science 261:1411-1418.
2. Battersby, T.R., Ang, D.N., Burgstaller, P., Jurczyk, S.C., Bowser, M.T., Buchanan, D.D., Kennedy, R.T., and Benner, S.A. 1999. Quantitative analysis of receptors for adenosine nucleotides obtained via in vitro selection from a library incorporating a cationic nucleotide analog. J. Am. Chem. Soc. 121:9781-9789.
3. Beaudry, A., DeFoe, J., Zinnen, S., Burgin, A., and Beigelman, L. 2000. In vitro selection of a novel nuclease-resistant RNA phosphodiesterase. Chem. Biol. 7:323-334.
4. Bell,N.M. and Micklefield, J. 2009. Chemical modification of oligonucleotides for therapeutic, bioanalytical and other applications. Chembiochem 10:2691-2703.
5. Brieba, L.G. and Sousa, R. 2000. Roles of histidine 784 and tyrosine 639 in ribose discrimination by T7 RNA polymerase. Biochemistry 39:919-923.
6. Brody, E.N., Willis, N.C., Smith, J.D., Jayasena, S., Zichi, D., and Gold, L. 1999. The use of aptamers in large arrays for molecular diagnostics. J. Mol. Diagn. 4:381-388.
7. Bugaut, A., Toulmé, J.J., and Rayner, B. 2004. Use of dynamic combinatorial chemistry for the identification of covalently appended residues that stabilize oligonucleotide complexes. Angew. Chem. Int. Ed. Engl. 43:3144-3147.
8. Bugaut, A., Bathany, K., Schmitter, J.M., and Rayner, B. 2005. Target-induced selection of ligands from a dynamic combinatorial library of mono-and bi-conjugated oligonucleotides. Tetrahedron Lett. 46:687-690.
9. Bugaut, A., Toulmé, J.J., and Rayner, B. 2006. SELEX and dynamic combinatorial chemistry interplay for the selection of conjugated RNA aptamers. Org. Biomol. Chem. 4:4082-4088.
10. Burmeister, P.E., Lewis, S.D., Silva, R.F., Preiss, J.R., Horwitz, L.R., Pendergrast, P.S., Mc-Cauley, T.G., Kurz, J.C., Epstein, D.M.,Wilson, C., and Keefe, A.D. 2005. Direct in vitro selection of a 2'-O-methyl aptamer to VEGF. Chem. Biol. 12:25-33.
11. Burmeister, P.E. Wang, C., Killough, J.R., Lewis, S.D., Horwitz, L.R., Ferguson, A., Thompson, K.M., Pendergrast, P.S., McCauley, T.G., Kurz, M., Diener, J., Cload, S.T., Wilson, C., and Keefe, A.D. 2006. 2'-Deoxy purine, 2'-O-methyl pyrimidine (dRmY) aptamers as candidate therapeutics. Oligonucleotides 16:337-351.
12. Chakravarthy, U., Adamis, A.P., Cunningham, E.T., Goldbaum, M., Guyer, D.R., Katz, B., and Patel, M. 2006. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology 113:1-25.
13. Chelliserrykattil, J. and Ellington, A.D. 2004. Evolution of a T7 RNA polymerase variant that transcribes 2'-O-methyl RNA. Nat. Biotechnol. 22:1155-1160.
14. Eulberg, D. and Klussman, S. 2003. Spiegelmers: Biostable aptamers. Chembiochem 4:979-983.
15. Faulhammer, D. and Famulok, M. 1997. Characterization and divalent metal-ion dependence of in vitro selected deoxyribozymes which cleave DNA/RNA chimeric oligonucleotides. J. Mol. Biol. 269:188-202.
16. Geyer, C. R. and Sen, D. 1997. Evidence for the metal-cofactor independence of an RNA phosphodiester-cleaving DNA enzyme. Chem. Biol. 4:579-593.
17. Gold, L., Ayer, D., Bertino, J., Bock, C., Bock, A., Brody, E.N., Carter, J., Dalby, A.B., Eaton, B.E., Fitzwater, T., Flather, D., Forbes, A., Foreman, T., Fowler, C., Gawande, B., Goss, M., Gunn, M., Gupta, S., Halladay, D., Heil, J., Heilig, J., Hicke, B., Husar, G., Janjic, N., Jarvis, T., Jennings, S., Katilius, E., Keeney, T.R., Kim, N., Koch, T.H., Kraemer, S., Kroiss, L., Le, N., Levine, D., Lindsey, W., Lollo, B., Mayfield, W., Mehan, M., Mehler, R., Nelson, S.K., Nelson, M., Nieuwlandt, D., Nikrad, M., Ochsner, U., Ostroff, R.M., Otis, M., Parker, T., Pietrasiewicz, S., Resnicow, D.I., Rohloff, J., Sanders, G., Sattin, S., Schneider, D., Singer, B., Stanton, M., Sterkel, A., Stewart, A., Stratford, S., Vaught, J.D., Vrkljan, M., Walker, J.J., Watrobka, M., Waugh, S., Weiss, A., Wilcox, S.K., Wolfson, A., Wolk, S.K., Zhang, C., and Zichi, D. 2010. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoSONE. 5:e15004.
18. Golden, M.C., Collins, B.D., Willis, M.C., and Koch, T.H. 2000. Diagnostic potential of photo-SELEX-evolved ssDNA aptamers. J. Biotechnol. 81:167-178.
19. Gourlain, T., Sidorov, A., Mignet, N., Thorpe, S.J., Lee, S.E., Grasby, J.A., and Williams, D.M. 2001. Enhancing the catalytic repertoire of nucleic acids. II. Simultaneous incorporation of amino and imidazolyl functionalities by two modified triphosphates during PCR. Nucleic Acids Res. 29:1898-1905.
20. Green, L.S., Jellinek, D., Bell, C., Beebe, L.A., Feistner, B.D., Gill, S.C., Jucker, F.M., and Janjic, N. 1995. Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chem. Biol. 2:683-695.
21. Griffiths, A.D., Potter, B.V., and Eperon, I.C. 1987. Stereospecificity of nucleases towards phosphorothioate-substituted RNA: Stereochemistry of transcription by T7 RNA polymerase. Nucleic Acids Res. 15:4145-4162.
22. He, W., Elizondo-Riojas, M.A., Li, X., Lokesh, G.L.R., Somasunderam, A., Thiviyanathan, V., Volk, D.E., Durland, R.H., Englehardt, J., Cavasotto, C.N., and Gorenstein, D.G. 2012. XAptamers: A bead based selection method for random incorporation of druglike moieties onto next-generation aptamers for enhanced binding. Biochemistry 51:8321-8323.
23. Hollenstein, M., Hipolito, C.J., Lam, C.H., and Perrin, D.M. 2013. Toward the combinatorial selection of chemically modified DNAzyme RNaseA mimics active against all-RNA substrates. ACS Comb. Sci. 15:174-182.
24. Huang, Y., Eckstein, F., Padilla, R., and Sousa, R. 1997. Mechanism of ribose 2'-group discrimination by an RNA polymerase. Biochemistry 36:8231-8242.
25. Ibach, J., Dietrich, L., Koopmans, K.R., Nöbel, N., Skoupi, M., and Brakmann, S. 2013. Identification of a T7 RNA polymerase variant that permits the enzymatic synthesis of fully 2'-Omethyl-modified RNA. J. Biotechnol. 167:287-295.
26. Jäger, S., Rasched, G., Kornreich-Leshem, H., Engeser, M., Thum, O., and Famulok, M. 2005. A versatile toolbox for variable DNA functionalization at high density. J. Am. Chem. Soc. 127:15071-15082.
27. Jellinek,D., Green, L.S., Bell, C., Lynott, C.K.,Gill, N., Vargeese, C., Kirschenheuter, G., McGee, D.P., Abesinghe, P., Pieken, W.A., Shapiro, R., Rifkin,D.B., Moscatelli, D., and Janjic, N. 1995. Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry 34:11363-11372.
28. Jhaveri, S., Olwin, B., and Ellington, A.D. 1998. In vitro selection of phosphorothiolated aptamers. Bioorg. Med. Chem. Lett. 8: 2285-2290.
29. Kasahara, Y., Irisawa, Y., Ozaki, H., Obika, H., and Kuwahara, M. 2013. 2',4'-BNA/LNA aptamers: CS-SELEX using a DNA-based library of fulllength 2'-O,4'-C-methylene-bridged/linked bicyclic ribonucleotides. Bioorg. Med. Chem. Lett. 23:1288-1292.
30. Kato, Y., Minakawa, N., Komatsu, Y., Kamiya, H., Ogawa, M., Harashima, H., and Matsuda, A., 2005. New NTP analogs: The synthesis of 4'-thioUTP and 4'-thioCTP and their utility for SELEX. Nucleic Acids Res. 33:2942-2951.
31. Keefe, A.D. and Cload, S.T. 2008. SELEX with modified nucleotides. Curr. Opin. Chem. Biol. 12:448-456.
32. Kimoto, M., Yamashige, R., Matsunaga, K., Yokoyama, S., and Hirao, I. 2013. Generation of high-affinity DNA aptamers using an expanded genetic alphabet. Nat. Biotechnol. 31: 453-457.
33. King, D.J.,Ventura,D.A., Brasier, A.R., and Gorenstein, D.G. 1998. Novel combinatorial selection of phosphorothioate oligonucleotide aptamers. Biochemistry 37:16489-16493.
34. King, D.J., Bassett, S.E., Li, X., Fennewald, S.A., Herzog, N.A., Luxong, B.A., Shope, R., and Gorenstein, D.G. 2002. Combinatorial selection and binding phosphorothioate aptamers targeting human NF-kappa B RelA (p65) and p50. Biochemistry. 41:9696-9706.
35. Koizumi, M., Soukup, G.A., Kerr, J.N., and Breaker, R.R. 1999. Allosteric selection of ribozymes that respond to the second messengers cGMP and cAMP. Nat. Struct. Biol. 6:1062-1071.
36. Kojima, T., Furukawa, K., Maruyama, H., Inoue, N., Tarashima, N., Matsuda, A., and Minakawa, N. 2013. PCR amplification of 4'-thioDNA using 2'-deoxy-4'-thionucleoside 5'-triphosphates. ACS Synth. Biol. 2:529-536.
37. Kore, A.R., Vaish, N.K.,Morris, J.A., and Eckstein, F. 2000. In vitro evolution of the hammerhead ribozyme to a purine-specific ribozyme using mutagenic PCR with two nucleotide analogues. J. Mol. Biol. 301:1113-1121.
38. Kostyuk, D.A., Dragan, S.M., Lyakhov, D.L., Rechinsky, V.O., Tunitskaya, V.L., Chernov, B.K., and Kochetkov, S.N. 1995. Mutants of T7 RNApolymerase that are able to synthesize both RNA and DNA. FEBS Lett. 369:165-168.
39. Kubik, M.F., Bell, C., Fitzwater, T., Watson, S.R., and Tasset, D.M. 1997. Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFNgamma that inhibit receptor binding. J. Immunol. 159:259-267.
40. Kujau, M.J., Siebert, A., and Wolfl, S. 1997. Design of leader sequences that improve the efficiency of the enzymatic synthesis of 2'-amino-pyrimidine RNA for in vitro selection. J. Biochem. Biophys. Methods 35:141-151.
41. Kuwahara, M., Takano, Y., Kasahara, Y., Nara, H., Ozaki, H., Sawai, H., Sugiyama, A., and Obika, S. 2010. Study on suitability of KODDNA polymerase for enzymatic production of artificial nucleic acids using base/sugar modified nucleoside triphosphates. Molecules 15:8229-8240.
42. Latham, J.A., Johnson, R., and Toole, J.J. 1994. The application of a modified nucleotide in aptamer selection: Novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine. Nucleic Acids Res. 22:2817-2822.
43. Lato, S.M., Ozerova, N.D.S, He, K., Sergueeva, Z., Shaw, B.R., and Burke, D.H. 2002. Boroncontaining aptamers to ATP. Nucleic Acids Res. 30:1401-1407.
44. Levy, M. and Ellington, A.D. 2001. Section of deoxyribozyme ligases that catalyze the formation of an unnatural internucleotide linkage. Bioorg. Med. Chem. 9:2581-2587.
45. Levy, M. and Ellington, A.D. 2002. In vitro selection of a deoxyribozyme that can utilize multiple substrates. J. Mol. Evol. 54:180-190.
46. Li, M., Lin, N., Huang, Z., Du, L., Altier, C., Fang, H., and Wang, B. 2008. Selecting aptamers for a glycoprotein through the incorporation of boronic acid moiety. J. Am. Chem. Soc. 130:12636-12638.
47. Lin,Y.,Qiu,Q., Gill, S.C., and Jayasena, S.D. 1994. Modified RNA sequence pools for in vitro selection. Nucleic Acids Res. 22:5229-5234.
48. Lutz, M.J., Horlacher, J., and Benner, S.A. 1998. Recognition of a non-standard base pair by thermostable DNA polymerases. Bioorg. Med. Chem. Lett. 8:1149-1152.
49. Lutz, S., Burgstaller, P., and Benner, S.A. 1999. An in vitro screening technique for DNA polymerases that can incorporate modified nucleotides. Pseudo-thymidine as a substrate for thermostable polymerases. Nucleic Acids Res. 27:2792-2798.
50. Maden, B.E.H. 1990. The numerous modified nucleotides in eukaryotic ribosomal RNA. Prog. Nucl. Acid Res. Mol. Biol. 39:241-303.
51. Mallikaratchy, P., Tang, Z., Kwame, S., Meng, L., Shangguan, D., and Tan, W. 2007. Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol. Cell. Proteomics. 6:2230-2238.
52. Marshall, K.A. and Ellington, A.D. 1999. Molecular parasites that evolve longer genomes. J. Mol. Evol. 49:656-663.
53. Mayer, G. 2009. The chemical biology of aptamers. Angew. Chem. Int. Ed. Engl. 48:2672-2689.
54. Mehan, M.R., Ostroff, R., Wilcox, S.K., Steele, F., Schneider, D., Jarvis, T.C., Baird, G.S., Gold, L., and Janjic, N. 2013. Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics. Adv. Exp. Med. Biol. 734:283-300.
55. Milligan, J.F. and Uhlenbeck, O.C. 1989. Synthesis of small RNAs using T7 RNA polymerase. Meth. Enzymol. 180:51-62.
56. Minakawa, N., Sanji, M., Kato, Y., and Matsuda, A. 2008. Investigations toward the selection of fully-modified 4'-thioRNAaptamers:Optimization of in vitro transcription steps in the presence of 4'-thioNTPs. Bioorg. Med. Chem. 16:9450-9456.
57. Nakamaye, K.L., Gish, G., Eckstein, F., and Vosberg, H.P. 1988. Direct sequencing of polymerase chain reaction amplified DNA fragments through the incorporation of deoxynucleoside alpha-thiotriphosphates. Nucleic Acids Res. 16:9947-9959.
58. Nieuwlandt, D., West, M., Cheng, X., Kirshenheuter, G., and Eaton, B.E. 2003. The first example of an RNA urea synthetase: Selection through the enzyme active site of human neutrophile elastase. Chem. Biol. Chem. 4:649-662.
59. Ochsner, U.A., Katilius, E., and Janjic, N. 2013. Detection of Clostridium difficile toxins A, B and binary toxin with slow off-rate modified aptamer. Diagn. Microbiol. Infect. Dis. 76:278-285.
60. Padilla, R. and Sousa, R. 1999. Efficient synthesis of nucleic acids heavily modified with noncanonical ribose 2'-groups using a mutantT7 RNA polymerase (RNAP). Nucleic Acids Res. 27:1561-1563.
61. Padilla, R. and Sousa, R. 2002.AY639F/H784A T7 RNA polymerase double mutant displays superior properties for synthesizing RNAs with noncanonical NTPs. Nucleic Acids Res. 30:e138.
62. Pagratis, N.C., Bell, C., Chang, Y.F., Jennings, S., Fitzwater, T., Jellinek, D., and Dang, C. 1997. Potent 2'-amino-and 2'-fluoro-2'-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nat. Biotechnol. 15:68-73.
63. Perrin, D.M., Garestier, T., and Helene, C. 2001. Bridging the gap between proteins and nucleic acids: A metal-independent RNAseA mimic with two protein-like functionalities. J. Am. Chem. Soc. 123:1556-1563.
64. Piccirilli, J.A., Krauch, T.,Moroney, S.E., and Benner, S.A. 1990. Enzymatic incorporation of a new base pair into DNA and RNA extends the genetic alphabet. Nature 343:33-37.
65. Robertson, M.P. 2001. Ph.D. dissertation. Engineered regulation of an RNA ligase ribozyme. University of Texas, Austin, Texas.
66. Robertson, M.P. and Ellington, A.D. 1999. In vitro selection of an allosteric ribozyme that transduces analytes to amplicons. Nat. Biotechnol. 17:62-66.
67. Robertson, M.P., Hesselberth, J.R., and Ellington, A.D. 2001. Optimization and optimality of a short ribozyme ligase that joins non-Watson-Crick base pairings. RNA 7:513-523.
68. Ruckman, J., Green, L.S., Beeson, J., Waugh, S., Gillette, W.L., Henninger, D.D., Claesson-Welsh, L., and Janjic, N. 1998. 2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J. Biol. Chem. 273:20556-20567.
69. Sakthivel, K. and Barbas, C.F. 1998. Expanding the potential of DNA for binding and catalysis: Highly functionalized dUTP derivatives that are substrates for thermostable DNA polymerases. Angew. Chem. Intl. Ed. 37:2872-2875.
70. Santoro, S.W. and Joyce, G.F. 1997. A general purpose RNA-cleaving DNA enzyme. Proc. Natl. Acad. Sci. U.S.A. 94:4262-4266.
71. Santoro, S.W., Joyce, G.F., Sakthivel, K., Gramatikova, S., and Barbas, C.F. III. 2000. RNA cleavage by a DNA enzyme with extended chemical functionality. J. Am. Chem. Soc. 122:2433-2439.
72. Schoetzau, T., Langner, J.,Moyround, E., Roehl, I., Vonhoff, S., and Klussmann, S. 2003. Amino modified nucleobases: Functionalized nucleoside triphosphates applicable for SELEX. Bioconjug. Chem. 14:919-926.
73. Seelig, B. and Jaschke, A. 1999. A small catalytic RNA motif with Diels-Alderase activity. Chem. Biol. 6:167-176.
74. Siegmund, V., Santner, T., Micura, R., andMarx, A. 2011. Enzymatic synthesis of 2'-methylselenomodified RNA. Chem. Sci. 2:2224-2231.
75. Siegmund, V., Santner, T., Micura, R., and Marx, A. 2012. Screening mutant libraries of T7 RNA polymerase for candidateswith increased acceptance of 2'-modified nucleotides. Chem. Commun. 48:9870-9872.
76. Shoji, A., Kuwahara, M., Ozaki, H., and Sawai, H. 2007. Modified DNA aptamer that binds the (R)-isomer of thalidomide derivative with high enantioselectivity. J. Am. Chem. Soc. 129:1456-1464.
77. Slatko, B.E., Albright, L.M., Tabor, S., and Ju, J. 1999. DNA sequencing by the dideoxy method. Curr. Protoc. Mol. Biol. 47:7.4A.1-7.4A.39.
78. Smith, D., Collins, B.D., Heil, J., and Koch, T.H. 2003. Sensitivity and specificity of photoaptamer probes. Mol. Cell. Proteomics 2:11-18.
79. Sousa, R. and Padilla, R. 1995. A mutant T7 RNA polymerase as a DNA polymerase. EMBO J. 14:4609-4621.
80. Southworth, M.W., Kong, H., Kucera, R.B., Ware, J., Jannasch, H.W., and Perler, F.B. 1996. Cloning of thermostable DNA polymerases from hyperthermophilic marine Archaea with emphasis on Thermococcus sp. 9°N-7 and mutations affecting 3'-5' exonuclease activity. Proc. Natl. Acad. Sci. U.S.A. 93:5281-5285.
81. Tarasow, T.M., Tarasow, S.L., and Eaton, B.E. 1997. RNA-catalysed carbon-carbon bond formation. Nature 389:54-57.
82. Teramoto, N., Imanishi, Y., and Ito, Y. 2000. In vitro selection of a ligase ribozyme carrying alkylamino groups in the side chains. Bioconjug. Chem. 11:744-748.
83. Vaught, J.D., Bock, C., Carter, J., Fitzwater, T., Otis, M., Schneider, D., Rolando, J.,Waugh, S., Wilcox, S.K., and Eaton, B.E. 2010. Expanding the chemistry of DNA for in vitro selection. J. Am. Chem. Soc. 132:4141-4151.
84. Veedu, R.N. and Wengel, J. 2010. Locked nucleic acids: Promising nucleic acid analogs for therapeutic applications. Chem. Biodivers. 7: 536-542.
85. Waters, E.K., Genga, R.M., Schwartz, M.C., Nelson, J.A., Schaub, R.G., Olson, K.A., Kurz, J.C., and McGinness, K.E. 2011. Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor. Blood 117:5277-5278.
86. Wilson, C. and Keefe, A.D. 2006. Building oligonucleotide therapeutics using non-natural chemistries. Curr. Opin. Chem. Biol. 10:607-614.
87. Wiegand, T.W., Janssen, R.C., and Eaton, B.E. 1997. Selection of RNA amide synthases. Chem. Biol. 4:675-683.
88. Wlotzka, B., Leva, S., Eschgfäller, B., Burmeister, J., Kleinjung, F., Kaduk, C., Muhn, P., Hess-Stumpp, H., and Klussmann, S. 2002. In vivo properties of an anti-GnRH Spiegelmer: An example of an oligonucleotide-based therapeutic substance class. Proc. Natl. Acad. Sci. U.S.A. 99:8898-8902.
89. Yang, Z., Chen, F., Alvarado, J.B., Benner, S.A. 2011. Amplification, mutation, and sequencing of a six-letter synthetic genetic system. J. Am. Chem. Soc. 133:15105-15112.
90. Zaccolo, M., Williams, D.M., Brown, D.M., and Gherardi, E. 1996. An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. J. Mol. Biol. 255:589-603.
91. Zon, G. and Geiser, T.G. 1991. Phosphorothioate oligonucleotides: Chemistry, purification, analysis, scale-up and future directions. Anticancer Drug Des. 6:539-568.